VHCP Management II as of Dec. 31, 2019
Portfolio Holdings for VHCP Management II
VHCP Management II holds 20 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| 10x Genomics Inc Cl A (TXG) | 35.9 | $136M | 1.8M | 76.25 | |
| Axsome Therapeutics (AXSM) | 21.4 | $81M | 786k | 103.36 | |
| Constellation Pharmceticls I | 18.6 | $71M | 1.5M | 47.11 | |
| Biohaven Pharmaceutical Holding | 6.6 | $25M | 463k | 54.44 | |
| Shockwave Med (SWAV) | 3.3 | $13M | 289k | 43.92 | |
| Iveric Bio | 2.3 | $8.6M | 1.0M | 8.58 | |
| Kalvista Pharmaceuticals (KALV) | 1.7 | $6.5M | 366k | 17.81 | |
| Obseva Sa | 1.6 | $6.0M | 1.6M | 3.82 | |
| Mersana Therapeutics (MRSN) | 1.4 | $5.3M | 923k | 5.73 | |
| Spero Therapeutics (SPRO) | 1.2 | $4.6M | 474k | 9.62 | |
| Relmada Therapeutics (RLMD) | 1.2 | $4.5M | 115k | 39.00 | |
| Adverum Biotechnologies | 1.2 | $4.4M | 384k | 11.52 | |
| Marinus Pharmaceuticals | 0.8 | $3.2M | 1.5M | 2.16 | |
| Forty Seven | 0.8 | $3.1M | 78k | 39.38 | |
| Milestone Pharmaceuticals (MIST) | 0.6 | $2.4M | 149k | 16.01 | |
| Nextcure (NXTC) | 0.5 | $2.0M | 36k | 56.33 | |
| Myovant Sciences | 0.3 | $1.2M | 77k | 15.51 | |
| 89bio (ETNB) | 0.3 | $1.1M | 41k | 26.29 | |
| Bellerophon Therapeutics | 0.1 | $231k | 659k | 0.35 | |
| Protagonist Therapeutics (PTGX) | 0.1 | $227k | 32k | 7.05 |
